Painters May Have Higher Risk of Bladder Cancer (07/29/2010)
Occupational exposures appear to increase bladder cancer risk in painters, according to a study published in Occupational and Environmental Medicine.

FDA Advisory Committee Recommends that Avastin No Longer Be Approved for Breast Cancer (07/29/2010)
The Oncology Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) has voted 12 to one that Avastin® (bevacizumab) in combination with paclitaxel should no longer be approved for initial therapy for metastatic HER2-negative breast cancer.

Neoadjuvant Chemotherapy Regimen Promising for Metastatic Penile Cancer (07/28/2010)

Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients May Benefit from Sprycel/Chemotherapy Combination (07/28/2010)
The initial report of a Phase II study evaluating Sprycel® (dasatinib) combined with chemotherapy for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) indicates that 94% of patients achieve a complete remission. These findings were recently published in the journal Blood.

Childhood Cancer Survivors Experience Elevated Risk of Premature Death Years after Diagnosis (07/27/2010)
Childhood cancer survivors may experience a persistently higher risk of premature death due to disease compared with the general population. These findings were recently published in the Journal of the American Medical Association.